Relating to: excepting xylazine testing materials from the definition of drug paraphernalia and civil and criminal liability exemptions for distributing and administering xylazine testing products.
Bill status
signed
all 5 stages cleared
Introduction
Jan 2024
Committee Review
Feb 2024
Senate Passage
Feb 2024
Assembly Passage
Feb 2024
Signed into Law
Mar 2024
Introduced Jan 5, 2024
Signed Mar 27, 2024
Floor votes
How they voted
This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history
Actions timeline
Total actions
31
Key actions
5
Committee
3
Mar 27, 2024
Signed into law
Report approved by the Governor on 3-26-2024. 2023 Wisconsin Act 217
upper
Feb 20, 2024
Lower · Passed
Read a third time and concurred in
lower
Feb 15, 2024
Lower · Passed
Placed on calendar 2-20-2024 by Committee on Rules
lower
Feb 14, 2024
Committee
Read first time and referred to committee on Rules
lower
Feb 13, 2024
Upper · Passed
Read a third time and passed
upper
Feb 2, 2024
Upper · Passed
Report passage recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 5, Noes 0
upper
Jan 5, 2024
Introduced
Introduced by Senators James, Agard, L. Johnson, Pfaff, Roys, Spreitzer and Larson;
cosponsored by Representatives Kitchens, Billings, C. Anderson, Behnke, Conley, Considine, Dittrich, Duchow, Gundrum, Jacobson, Mursau, Myers, Nedweski, Ohnstad, Ortiz-Velez, Palmeri, Rozar, Shankland, Sinicki and Subeck
upper
7 primary · 0 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 875
Scope: WI
Hi! I can help you understand SB 875. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline